EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The impact of human milk oligosaccharides and galacto-oligosaccharides on the growth of early life pathogenic gut bacteria

Job T S Schlösser, Wendy W J Unger, Ad C J M de Bruijn, Dianne J Delsing, Andre Groeneveld, Arjen Nauta, Gert Folkerts, Marc M S M Wösten, Saskia Braber

Frontiers in Microbiology · 28.07.2026 · 17

DOI: 10.3389/fmicb.2026.1854651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 28.07.2026. Verfasst von Job T S Schlösser und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotics are widely used to prevent and treat early life gut infections, but their aberrant use has raised global concerns about antibiotic resistance. As breastfed infants have fewer intestinal infections than formula-fed infants, this stimulated scientific interest in the anti-pathogenic properties of breastmilk, specifically human milk oligosaccharides (HMOs). HMOs are non-digestible sugars that support infant gut microbiome development, immune maturation, and protection against pathogens. However, to determine how specific HMO structures differentially affect microbial growth and pathogen susceptibility investigating individual HMOs is essential. This study therefore evaluates the effects of single-structure HMOs and galacto-oligosaccharides (GOS) on the growth of key early-life gut pathogens, Escherichia coli, Salmonella enterica, Yersinia enterocolitica , and Clostridium perfringens . The strongest pathogen inhibitory effects of HMOs were further assessed by colony forming unit enumeration and tested across variable media to confirm oligosaccharide-specific efficacy. Oligosaccharide screening revealed clear differences in bacterial growth, with S. enterica most strongly inhibited and C. perfringens exhibiting growth stimulation. Among the tested oligosaccharides, 3′-galactosyllactose and GOS showed the most pronounced growth-inhibitory effects against Escherichia coli, Salmonella enterica, Yersinia enterocolitica . Salt concentration and nutrient richness further modulated oligosaccharide activity, highlighting the multifactorial nature of their antibacterial potential. Overall, our findings show that oligosaccharides display structure-specific and environment-dependent effects on bacterial growth, indicating that their antimicrobial activity is shaped by oligosaccharide structure, bacterial species, and growth environment.

Schlagwörter

Stichwörter der Autor:innen

antibiotic alternativesbacterial growthculture mediaearly life intestinal pathogensgalacto-oligosaccharideshuman milk oligosaccharides

Autor:innen und Institutionen

  • Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands.
  • Laboratory of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MC University Medical Center Rotterdam - Sophia Children's Hospital, Rotterdam, Netherlands.
  • Friesland Campina, Amersfoort, Netherlands.
  • Division of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.

Zitieren

APA

Schlösser, J. T. S., Unger, W. W. J., de Bruijn, A. C. J. M., Delsing, D. J., Groeneveld, A., Nauta, A., Folkerts, G., Wösten, M. M. S. M., & Braber, S. (2026). The impact of human milk oligosaccharides and galacto-oligosaccharides on the growth of early life pathogenic gut bacteria. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1854651

Vancouver

Schlösser JTS, Unger WWJ, de Bruijn ACJM, Delsing DJ, Groeneveld A, Nauta A, et al. The impact of human milk oligosaccharides and galacto-oligosaccharides on the growth of early life pathogenic gut bacteria. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1854651

BibTeX
@article{Schlsser2026,
  author = {Schlösser, Job T S and Unger, Wendy W J and de Bruijn, Ad C J M and Delsing, Dianne J and Groeneveld, Andre and Nauta, Arjen and Folkerts, Gert and Wösten, Marc M S M and Braber, Saskia},
  title = {The impact of human milk oligosaccharides and galacto-oligosaccharides on the growth of early life pathogenic gut bacteria},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1854651}
}
Kostenlos starten →